Design, Synthesis and Biological Evaluation of Novel Piperazinone Derivatives as Cytotoxic Agents

被引:10
作者
Ghaseml, Saeed [1 ]
Sharifi, Simin [2 ]
Mojarrad, Javid Shahbazi [3 ]
机构
[1] Guilan Univ Med Sci, Sch Pharm, Dept Med Chem, Rasht, Iran
[2] Tabriz Univ Med Sci, Dent & Periodontal Res Ctr, Tabriz, Iran
[3] Tabriz Univ Med Sci, Fac Pharm, Dept Med Chem, Tabriz, Iran
关键词
Anticancer activity; Bioisosteric replacement; Piperazinone; Chemical synthesis; CONTAINING FARNESYLTRANSFERASE INHIBITORS; DISCOVERY; THIOUREA; LIBRARY; 3D-QSAR; MOIETY; CANCER; SERIES;
D O I
10.34172/apb.2020.051
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: In this study, a series of piperazin-2-one derivatives were prepared through bioisosteric substitution of the imidazole ring of L-778,123 (imidazole-containing FTase inhibitor) and rearrangement of groups based on the tipifarnib structure. Final compounds were evaluated for their cytotoxic activities on cancer and normal cell lines by MTT assay. Methods: Methyl alpha-bromophenylacetic acid and 1-(3-chlorophenyl) piperazin-2-one were synthesized using previously described methods. Methyl 2-(4-chlorophenyl)-2-(4-(3-chlorophenyl)-3-oxopiperazin-1-yl) acetate was prepared by reaction between these two compounds in presence of potassium carbonate. Finally, methoxy group of ester was substituted by various amines such as guanidine, thiourea, urea and hydrazide. The synthesized compounds were tested for their cytotoxicity against colon cancer (HT-29) and lung cancer (A549) cell lines as well as MRC-5 (normal fetal lung fibroblasts) cells as a healthy cell line using MTT colorimetric assay method. Results: Replacement of imidazole moiety with guanidine, thiourea, and hydrazide could increase cytotoxicity toward all three cell lines. Some substituents, such as amine, urea, and hydroxylamine exhibited significant cytotoxicity (<500 mu M) but lower than L-778,123 as standard compound. Hydroxyl and methoxy substituents did not show significant cytotoxicity. Imidazole substituent group revealed cytotoxicity similar to L-778,123 All compounds showed lower cytotoxic activity against normal cell lines compared with cancer cell lines. Conclusion: It seems the electron density of substituted groups and rearrangement of groups may significantly increase cytotoxic activity.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 39 条
[1]   Synthesis and biological evaluation of 2-phenylthiazole-4-carboxamide derivatives as anticancer agents [J].
Aliabadi, Alireza ;
Shamsa, Fazel ;
Ostad, Seyed Nasser ;
Emami, Saeed ;
Shafiee, Abbas ;
Davoodi, Jamshid ;
Foroumadi, Alireza .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (11) :5384-5389
[2]   4-methyl-1,2,4-triazol-3-yl heterocycle as an alternative to the 1-methylimidazol-5-yl moiety in the farnesyltransferase inhibitor ZARNESTRA™ [J].
Angibaud, P ;
Saha, AK ;
Bourdrez, X ;
End, DW ;
Freyne, E ;
Lezouret, P ;
Mannens, G ;
Mevellec, L ;
Meyer, C ;
Pilatte, I ;
Poncelet, V ;
Roux, B ;
Smets, G ;
Van Dun, J ;
Venet, M ;
Wouters, W .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (24) :4361-4364
[3]   5-imidazolyl-quinolinones, -quinazolinones and -benzo-azepinones as farnesyltransferase inhibitors [J].
Angibaud, P ;
Bourdrez, X ;
Devine, A ;
End, DW ;
Freyne, E ;
Ligny, Y ;
Muller, P ;
Mannens, G ;
Pilatte, I ;
Poncelet, V ;
Skrzat, S ;
Smets, G ;
Van Dun, J ;
Van Remoortere, P ;
Venet, M ;
Wouters, W .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (09) :1543-1547
[4]   Impact on farnesyltransferase inhibition of 4-chlorophenyl moiety replacement in the Zarnestra® series [J].
Angibaud, Patrick ;
Mevellec, Laurence ;
Meyer, Christophe ;
Bourdrez, Xavier ;
Lezouret, Patricia ;
Pilatte, Isabelle ;
Poncelet, Virginie ;
Roux, Bruno ;
Merillon, Sophie ;
End, David W. ;
Van Dun, Jacky ;
Wouters, Walter ;
Venet, Marc .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2007, 42 (05) :702-714
[5]   Development of farnesyl transferase inhibitors: A review [J].
Appels, NMGM ;
Beijnen, JH ;
Schellens, JHM .
ONCOLOGIST, 2005, 10 (08) :565-578
[6]  
Askin D, 2000, Patent No. [US6160118, 6160118]
[7]   Peptidomimetic inhibitors of farnesyltransferase with high in vitro activity and significant cellular potency [J].
Bolchi, Cristiano ;
Pallavicini, Marco ;
Rusconi, Chiara ;
Diomede, Luisa ;
Ferri, Nicola ;
Corsini, Alberto ;
Fumagalli, Laura ;
Pedretti, Alessandro ;
Vistoli, Giulio ;
Valoti, Ermanno .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (22) :6192-6196
[8]   Thiazole- and imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase [J].
Bolchi, Cristiano ;
Pallavicini, Marco ;
Bernini, Sergio K. ;
Chiodini, Giuseppe ;
Corsini, Alberto ;
Ferri, Nicola ;
Fumagalli, Laura ;
Straniero, Valentina ;
Valoti, Ermanno .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (18) :5408-5412
[9]  
Bouisset M, 1991, Patent No. [US5036156, 5036156]
[10]   K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study [J].
Brink, M ;
de Goeij, AFPM ;
Weijenberg, MP ;
Roemen, GMJM ;
Lentjes, MHFM ;
Pachen, MMM ;
Smits, KM ;
de Bruïne, AP ;
Goldbohm, RA ;
van den Brandt, PA .
CARCINOGENESIS, 2003, 24 (04) :703-710